J Korean Diabetes Assoc.
2000 Dec;24(6):689-698.
The Serial Changes of Blood Glucose and Lipid Levels Following Allogeneic Bone Marrow
Transplantation and Related Clinical Factors
- Affiliations
-
- 1Department of Internal Medicine, The Catholic University of Korea, College of Medicine.
- 2Hemopoietic Stem Cell Transplantation center, Seoul, Korea.
- 3Mizmedi Hospital, Seoul, Korea.
Abstract
-
BACKGROUND: In bone marrow transplantation (BMT), recipients are usually younger
and immunosuppressants are open used in shorter period than in solid organ
transplantation. Therefore, there might be a difference in glucose and lipid
metabolism between BMT and solid organ transplantation. However, the serial
changes of metabolic parameters following BMT have not been studied. There
fore, the aim of this study is to investigate the serial changes of blood glucose,
lipids and the putative factors that are related with these changes after BMT.
METHODS
We have prospectively investigated 43 patients who underwent
allogeneic BMT . Fasting plasma glucose (FPG), total cholesterol, triglyceride and
high-density lipoprotein (HDL) were measured before BMT, and at 1, 2, 3, 4, 12
weeks and 6 months after BMT. The serial changes of these metabolic parameters
according to clinical factors including type of BMT, mean daily steroid dosage,
and occurrence of graft versus host disease (GVHD) were examined.
RESULTS
1. Mean FPG level increased during 4 weeks after BMT and remained
above basal value at post-transplant 6 months. Total Cholesterol level was
increased during initial 4 weeks after BMT and was above basal value at post-BMT
of 3 and 6 months. Triglyceride level was progressively increased during initial 4
weeks after BMT, but returned to basal value thereafter. HDL-cholesterol level was
significantly decreased during initial 4 weeks after BMT, but returned to basal
value thereafter.
2. Patients with FPG above 126 mg/dL at post-transplant 6 months were 7 out of
43 patients (16%). Comparing patients with FPG above 126 mg/dL and the other
patients, the former received larger amounts of daily steroid and had lower
HDL-cholesterol level.
3. The changes of metabolic parameters were different according to type of BMT,
steroid dose, and occurrence of GVHD.
CONCLUSION
Although there was increase of FPG, TC, TG and decrease of HDL-C
during initial 4 weeks after BMT, these metabolic changes recovered slowly
thereafter. Immunosuppressants are thought to be associated with these changes.
Further observation will be needed for the long-term effect of BMT on metabolic
changes.